<DOC>
	<DOCNO>NCT03051087</DOCNO>
	<brief_summary>compare evaluate efficacy safety Ganilever PFS Orgalutran® infertility woman assist reproductive technology</brief_summary>
	<brief_title>To Compare Evaluate Efficacy Safety Ganilever PFS ( Prefilled Syringe ) Orgalutran®</brief_title>
	<detailed_description />
	<mesh_term>Ganirelix</mesh_term>
	<criteria>An adult female age 20 39 time screen Patients whose mean menstrual cycle 25 35 day Patients whose FSH ( follicle stimulate hormone ) concentration exceed 13 mIU / mL screen Patients diagnosed infertility due one follow A . Trouble Factors B . Male Factors C. Unexplained D. Uterine factor Patients previous IVF experience le 3 Patient sign write consent hear explanation purpose , method effect clinical trial If sperm donor ( spouse nonspouse ) severe male factor ( Non obstructive azoospermia ) Patients diagnose PCOS ( polycystic ovary syndrome ) screen Patient abnormal uterine bleed screen Patients diagnose primary ovarian failure Patients ovarian cyst relate PCOS screen Patients tubal hydrops Patients untreated nonreproductive endocrine disease Patients deformity reproductive organ conceive , fibroid uterus conceive ( submucosal myoma ) Patients less 2 ovary ( 0 or1 ) Patients ovarian , breast , uterus , hypothalamus , pituitary malignancy Patients BMI &lt; 18 BMI &gt; 30 Patients LH concentration le 1.2mIU / mL screen Poor ovarian responder bologna criterion Patients moderate severe renal impairment ( creatinine clearance &lt; 60 mL / min ) liver function impairment ( ALT AST , &gt; 5 time normal ) Patients experience Grade 4 high OHSS ( ovarian hyperstimulation syndrome ) Patients contraindicated pregnancy Patients pregnant lactate Patients hypersensitivity IP Patients participate medicationrelated clinical trial since enrollment study , participate clinical trial within 3 month ( 90 day ) enrol trial</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>